CRBU
Caribou Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.30
−0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.42x
- Price / sales
- 13.89x
- Price / cash flow
- -1.46x
Enterprise value
- Enterprise value
- $53.7M
- EV / sales
- 5.35x
- EV / EBITDA
- -0.52x
- EV / EBIT
- -0.49x
- Market cap
- $139.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026